Craig D Platt, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Severe Combined Immunodeficiency | 4 | 2022 | 235 | 1.540 |
Why?
|
Immunologic Deficiency Syndromes | 6 | 2024 | 549 | 1.310 |
Why?
|
Lymphopenia | 3 | 2022 | 300 | 1.280 |
Why?
|
Agammaglobulinemia | 4 | 2022 | 174 | 0.810 |
Why?
|
Immunophenotyping | 2 | 2024 | 1864 | 0.770 |
Why?
|
B-Lymphocytes | 4 | 2024 | 4793 | 0.660 |
Why?
|
Lymphadenitis | 1 | 2019 | 99 | 0.610 |
Why?
|
Homozygote | 3 | 2019 | 1779 | 0.600 |
Why?
|
Umbilical Cord | 1 | 2019 | 179 | 0.590 |
Why?
|
T-Lymphocytes | 6 | 2024 | 10266 | 0.590 |
Why?
|
Epidermodysplasia Verruciformis | 1 | 2017 | 22 | 0.580 |
Why?
|
von Willebrand Disease, Type 3 | 1 | 2016 | 6 | 0.540 |
Why?
|
Janus Kinase 3 | 1 | 2016 | 76 | 0.540 |
Why?
|
BCG Vaccine | 1 | 2019 | 381 | 0.530 |
Why?
|
Pneumonia, Bacterial | 1 | 2019 | 320 | 0.530 |
Why?
|
Anion Transport Proteins | 1 | 2017 | 141 | 0.530 |
Why?
|
RNA Splice Sites | 1 | 2016 | 213 | 0.500 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 1 | 2019 | 905 | 0.490 |
Why?
|
Myeloid Differentiation Factor 88 | 1 | 2019 | 582 | 0.480 |
Why?
|
Flow Cytometry | 2 | 2024 | 5902 | 0.480 |
Why?
|
Epstein-Barr Virus Infections | 2 | 2019 | 617 | 0.470 |
Why?
|
Neutropenia | 1 | 2019 | 892 | 0.450 |
Why?
|
High-Throughput Nucleotide Sequencing | 5 | 2020 | 3671 | 0.440 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 572 | 0.440 |
Why?
|
von Willebrand Factor | 1 | 2016 | 680 | 0.400 |
Why?
|
Lymphohistiocytosis, Hemophagocytic | 3 | 2022 | 271 | 0.400 |
Why?
|
Actins | 1 | 2019 | 2064 | 0.400 |
Why?
|
Desensitization, Immunologic | 2 | 2020 | 558 | 0.390 |
Why?
|
Systemic Inflammatory Response Syndrome | 3 | 2021 | 621 | 0.370 |
Why?
|
Macrophage Activation Syndrome | 3 | 2022 | 124 | 0.370 |
Why?
|
Adenosine Deaminase | 2 | 2023 | 253 | 0.330 |
Why?
|
Skin | 2 | 2019 | 4503 | 0.310 |
Why?
|
Genetic Association Studies | 2 | 2021 | 2744 | 0.310 |
Why?
|
Genetic Predisposition to Disease | 8 | 2023 | 18065 | 0.300 |
Why?
|
Hematopoietic Stem Cell Transplantation | 4 | 2022 | 5717 | 0.290 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1437 | 0.280 |
Why?
|
Membrane Proteins | 3 | 2019 | 7876 | 0.260 |
Why?
|
Fatal Outcome | 3 | 2020 | 1836 | 0.260 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2020 | 667 | 0.250 |
Why?
|
Child, Preschool | 17 | 2023 | 42669 | 0.250 |
Why?
|
Endocytosis | 1 | 2010 | 956 | 0.250 |
Why?
|
Autoimmunity | 2 | 2023 | 1361 | 0.250 |
Why?
|
Consanguinity | 4 | 2022 | 460 | 0.230 |
Why?
|
Sequence Deletion | 2 | 2020 | 1497 | 0.230 |
Why?
|
Pedigree | 5 | 2023 | 4539 | 0.230 |
Why?
|
Mevalonate Kinase Deficiency | 1 | 2023 | 19 | 0.220 |
Why?
|
Receptors, Immunologic | 1 | 2010 | 1418 | 0.220 |
Why?
|
Sweet Syndrome | 1 | 2023 | 56 | 0.210 |
Why?
|
Haploinsufficiency | 2 | 2021 | 334 | 0.200 |
Why?
|
Infant | 11 | 2023 | 36535 | 0.200 |
Why?
|
Mutation | 13 | 2023 | 30238 | 0.190 |
Why?
|
Vasculitis | 2 | 2023 | 525 | 0.190 |
Why?
|
Lymphocyte Activation | 4 | 2022 | 5505 | 0.190 |
Why?
|
Receptors, IgE | 1 | 2022 | 375 | 0.180 |
Why?
|
Mutation, Missense | 2 | 2021 | 2592 | 0.180 |
Why?
|
Neonatal Screening | 2 | 2022 | 620 | 0.170 |
Why?
|
Child | 17 | 2023 | 80917 | 0.170 |
Why?
|
Meningitis, Bacterial | 1 | 2022 | 225 | 0.170 |
Why?
|
DNA-Binding Proteins | 1 | 2017 | 9615 | 0.170 |
Why?
|
STAT2 Transcription Factor | 1 | 2019 | 27 | 0.170 |
Why?
|
Mycobacterium bovis | 1 | 2020 | 148 | 0.170 |
Why?
|
Mycobacterium Infections | 1 | 2020 | 122 | 0.170 |
Why?
|
Dendritic Cells | 2 | 2010 | 2747 | 0.160 |
Why?
|
Ion Transport | 2 | 2018 | 322 | 0.160 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 299 | 0.160 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2020 | 147 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 2909 | 0.160 |
Why?
|
Humans | 44 | 2024 | 768166 | 0.150 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3238 | 0.150 |
Why?
|
Flagella | 1 | 2018 | 97 | 0.150 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2023 | 4415 | 0.150 |
Why?
|
Mice, Mutant Strains | 2 | 2021 | 1754 | 0.150 |
Why?
|
Streptococcal Infections | 1 | 2022 | 619 | 0.150 |
Why?
|
Burkitt Lymphoma | 1 | 2020 | 338 | 0.150 |
Why?
|
Genomics | 1 | 2013 | 5926 | 0.140 |
Why?
|
Interleukins | 1 | 2022 | 796 | 0.140 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.130 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2023 | 1656 | 0.130 |
Why?
|
Leukocyte Count | 1 | 2020 | 1609 | 0.130 |
Why?
|
Codon, Nonsense | 1 | 2017 | 287 | 0.130 |
Why?
|
Necrosis | 1 | 2019 | 1616 | 0.120 |
Why?
|
Lymphoproliferative Disorders | 1 | 2019 | 528 | 0.120 |
Why?
|
Infertility, Male | 1 | 2018 | 397 | 0.120 |
Why?
|
Virus Diseases | 1 | 2021 | 724 | 0.120 |
Why?
|
Cell Size | 1 | 2017 | 626 | 0.120 |
Why?
|
Immune System Diseases | 1 | 2017 | 253 | 0.120 |
Why?
|
Pseudomonas Infections | 1 | 2019 | 623 | 0.120 |
Why?
|
Phenotype | 6 | 2023 | 16726 | 0.120 |
Why?
|
Disease Susceptibility | 1 | 2021 | 1793 | 0.120 |
Why?
|
Genetic Diseases, Inborn | 1 | 2019 | 606 | 0.110 |
Why?
|
Skin Tests | 1 | 2016 | 639 | 0.110 |
Why?
|
Apoptosis | 2 | 2021 | 9523 | 0.110 |
Why?
|
Autoimmune Diseases | 2 | 2023 | 2257 | 0.110 |
Why?
|
Autoantibodies | 1 | 2022 | 2121 | 0.110 |
Why?
|
Psoriasis | 1 | 2022 | 926 | 0.110 |
Why?
|
Cytomegalovirus Infections | 1 | 2020 | 837 | 0.110 |
Why?
|
Herpesvirus 4, Human | 1 | 2019 | 1082 | 0.110 |
Why?
|
Antigens, Neoplasm | 1 | 2021 | 1997 | 0.110 |
Why?
|
Ubiquitin-Protein Ligases | 1 | 2022 | 1901 | 0.100 |
Why?
|
Male | 21 | 2023 | 364719 | 0.100 |
Why?
|
Female | 19 | 2023 | 397192 | 0.100 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1885 | 0.100 |
Why?
|
Cells, Cultured | 2 | 2019 | 19015 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3115 | 0.100 |
Why?
|
Thrombocytopenia | 1 | 2020 | 1179 | 0.100 |
Why?
|
Pharmaceutical Preparations | 1 | 2020 | 1088 | 0.100 |
Why?
|
Siblings | 1 | 2016 | 828 | 0.100 |
Why?
|
Sequence Analysis, DNA | 2 | 2020 | 4786 | 0.100 |
Why?
|
Opportunistic Infections | 1 | 2015 | 375 | 0.100 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2017 | 977 | 0.100 |
Why?
|
Drug Hypersensitivity | 1 | 2020 | 923 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2020 | 1886 | 0.090 |
Why?
|
Pseudomonas aeruginosa | 1 | 2019 | 1276 | 0.090 |
Why?
|
Immunologic Factors | 1 | 2020 | 1596 | 0.090 |
Why?
|
Allergens | 1 | 2018 | 1443 | 0.090 |
Why?
|
Food Hypersensitivity | 1 | 2018 | 734 | 0.090 |
Why?
|
Adolescent | 7 | 2023 | 89169 | 0.080 |
Why?
|
Genetic Counseling | 1 | 2013 | 635 | 0.080 |
Why?
|
Mice | 8 | 2022 | 82029 | 0.080 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3114 | 0.080 |
Why?
|
West Nile Fever | 1 | 2009 | 77 | 0.080 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2023 | 2442 | 0.080 |
Why?
|
Antibodies | 1 | 2017 | 2421 | 0.080 |
Why?
|
DNA Mutational Analysis | 1 | 2016 | 4120 | 0.080 |
Why?
|
Genetic Linkage | 1 | 2013 | 2342 | 0.070 |
Why?
|
Sensitivity and Specificity | 1 | 2023 | 14729 | 0.070 |
Why?
|
Young Adult | 4 | 2023 | 60066 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2023 | 22291 | 0.070 |
Why?
|
Infant, Newborn | 3 | 2023 | 26422 | 0.070 |
Why?
|
Microscopy, Electron | 1 | 2010 | 2560 | 0.070 |
Why?
|
Colitis | 1 | 2015 | 1242 | 0.070 |
Why?
|
Genetic Testing | 1 | 2019 | 3591 | 0.070 |
Why?
|
Quality Improvement | 2 | 2019 | 3857 | 0.070 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2010 | 1441 | 0.060 |
Why?
|
Alleles | 1 | 2016 | 6894 | 0.060 |
Why?
|
Mice, Knockout | 2 | 2018 | 14488 | 0.060 |
Why?
|
Biopsy | 1 | 2016 | 6793 | 0.060 |
Why?
|
Thymidylate Synthase | 1 | 2004 | 74 | 0.060 |
Why?
|
Animals | 9 | 2022 | 169246 | 0.060 |
Why?
|
Genes, Protozoan | 1 | 2004 | 170 | 0.060 |
Why?
|
Tetrahydrofolate Dehydrogenase | 1 | 2004 | 133 | 0.060 |
Why?
|
Phagocytosis | 1 | 2010 | 1530 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2018 | 3231 | 0.060 |
Why?
|
Adult | 7 | 2023 | 223646 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2020 | 14783 | 0.060 |
Why?
|
HEK293 Cells | 2 | 2023 | 4283 | 0.050 |
Why?
|
Genotype | 2 | 2020 | 13045 | 0.050 |
Why?
|
Janus Kinase 1 | 1 | 2023 | 108 | 0.050 |
Why?
|
Toxoplasma | 1 | 2004 | 159 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8748 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2010 | 2633 | 0.050 |
Why?
|
Aged | 4 | 2023 | 171504 | 0.050 |
Why?
|
Coatomer Protein | 1 | 2021 | 18 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 664 | 0.050 |
Why?
|
Cell Proliferation | 1 | 2017 | 10474 | 0.050 |
Why?
|
Streptococcus agalactiae | 1 | 2022 | 337 | 0.040 |
Why?
|
Antibody-Dependent Enhancement | 1 | 2020 | 15 | 0.040 |
Why?
|
Twins, Monozygotic | 1 | 2022 | 472 | 0.040 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5520 | 0.040 |
Why?
|
Middle Aged | 4 | 2023 | 223492 | 0.040 |
Why?
|
Red-Cell Aplasia, Pure | 1 | 2020 | 27 | 0.040 |
Why?
|
Severity of Illness Index | 1 | 2017 | 15948 | 0.040 |
Why?
|
Receptors, Peptide | 1 | 2021 | 280 | 0.040 |
Why?
|
Cell Differentiation | 1 | 2017 | 11669 | 0.040 |
Why?
|
Golgi Apparatus | 1 | 2021 | 406 | 0.040 |
Why?
|
Fibrinogen | 1 | 2022 | 891 | 0.040 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2020 | 425 | 0.040 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.040 |
Why?
|
Anions | 1 | 2018 | 137 | 0.040 |
Why?
|
Biological Transport, Active | 1 | 2018 | 323 | 0.040 |
Why?
|
Immunization, Passive | 1 | 2020 | 619 | 0.040 |
Why?
|
Otitis Media | 1 | 2020 | 288 | 0.040 |
Why?
|
Gene Expression | 3 | 2020 | 7598 | 0.040 |
Why?
|
Eczema | 1 | 2020 | 245 | 0.040 |
Why?
|
Nanoparticles | 1 | 2009 | 1985 | 0.040 |
Why?
|
Sperm Motility | 1 | 2018 | 265 | 0.030 |
Why?
|
Vaccination | 1 | 2009 | 3437 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1743 | 0.030 |
Why?
|
Immunoglobulin E | 1 | 2022 | 1506 | 0.030 |
Why?
|
Signal Transduction | 2 | 2023 | 23645 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2009 | 4937 | 0.030 |
Why?
|
Mucocutaneous Lymph Node Syndrome | 1 | 2020 | 539 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2013 | 11928 | 0.030 |
Why?
|
Retrospective Studies | 5 | 2023 | 81762 | 0.030 |
Why?
|
Adaptive Immunity | 1 | 2020 | 733 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2020 | 1183 | 0.030 |
Why?
|
Testis | 1 | 2018 | 783 | 0.030 |
Why?
|
Cytokines | 2 | 2021 | 7453 | 0.030 |
Why?
|
Genes, Recessive | 1 | 2017 | 625 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2021 | 1133 | 0.030 |
Why?
|
Iran | 1 | 2017 | 763 | 0.030 |
Why?
|
Spermatozoa | 1 | 2018 | 632 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2017 | 874 | 0.030 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.030 |
Why?
|
Transplantation, Homologous | 1 | 2021 | 4833 | 0.030 |
Why?
|
Anticonvulsants | 1 | 2022 | 1923 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2020 | 1014 | 0.020 |
Why?
|
Lung Diseases, Interstitial | 1 | 2021 | 940 | 0.020 |
Why?
|
China | 1 | 2018 | 2395 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2020 | 1751 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2021 | 2568 | 0.020 |
Why?
|
Infant, Premature | 1 | 2021 | 2124 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2019 | 4648 | 0.020 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2023 | 2171 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2020 | 3228 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2022 | 3858 | 0.020 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2020 | 2892 | 0.020 |
Why?
|
West Nile Virus Vaccines | 1 | 2009 | 4 | 0.020 |
Why?
|
Seizures | 1 | 2022 | 2998 | 0.020 |
Why?
|
Consensus | 1 | 2019 | 3212 | 0.020 |
Why?
|
Molecular Targeted Therapy | 1 | 2020 | 2830 | 0.020 |
Why?
|
Cell Survival | 1 | 2018 | 5777 | 0.020 |
Why?
|
Genetic Variation | 1 | 2023 | 6611 | 0.020 |
Why?
|
Immunity, Innate | 1 | 2020 | 3080 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8890 | 0.020 |
Why?
|
Polyglycolic Acid | 1 | 2009 | 408 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3706 | 0.020 |
Why?
|
Viral Envelope Proteins | 1 | 2009 | 640 | 0.020 |
Why?
|
RNA, Protozoan | 1 | 2004 | 46 | 0.010 |
Why?
|
Antibody Formation | 1 | 2009 | 1393 | 0.010 |
Why?
|
Lactic Acid | 1 | 2009 | 1140 | 0.010 |
Why?
|
Adjuvants, Immunologic | 1 | 2009 | 998 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2022 | 7477 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2019 | 13014 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 10840 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 12840 | 0.010 |
Why?
|
5' Untranslated Regions | 1 | 2004 | 255 | 0.010 |
Why?
|
Lung | 1 | 2021 | 10099 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 7454 | 0.010 |
Why?
|
Lipopolysaccharides | 1 | 2009 | 2219 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10873 | 0.010 |
Why?
|
Obesity | 1 | 2023 | 13090 | 0.010 |
Why?
|
Asthma | 1 | 2019 | 6291 | 0.010 |
Why?
|
Cohort Studies | 1 | 2023 | 41754 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2018 | 18349 | 0.010 |
Why?
|
Algorithms | 1 | 2019 | 14164 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2004 | 4620 | 0.010 |
Why?
|
Base Sequence | 1 | 2004 | 12421 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 5797 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 59629 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2004 | 17622 | 0.010 |
Why?
|
United States | 1 | 2019 | 73039 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2004 | 7608 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2009 | 22379 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2004 | 12800 | 0.010 |
Why?
|